The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
Open accessAbstract
OBJECTIVES: To review systematically the available literature on the optimal dosage and route of administration of methotrexate in patients with rheumatoid arthritis (RA), as an evidence base for generating clinical practice recommendations. METHODS: A systematic literature search was carried out in MEDLINE, EMBASE, Cochrane Library and American College of Rheumatology/European League Against Rheumatism meeting abstracts, searching for randomised controlled trials evaluating various dosages or routes of administration of methotrexate in RA. Articles that fulfilled predefined inclusion criteria were systematically reviewed and the quality was appraised. Effect sizes and odds ratios for clinical, radiological and toxicity outcomes were calculated and directly or indirectly compared between study groups using methotrexate in different dosages or by different routes. RESULTS: A total of 38 publications out of 1748 identified references was included in the review. Start doses of 25 mg/week or fast escalation with 5 mg/month to 25-30 mg/week were associated with higher clinical effect sizes and more (gastrointestinal) adverse events in comparison with doses of 5-15 mg/week or slow escalation. Starting with 15 mg/week subcutaneous versus oral methotrexate was associated with higher clinical efficacy but more withdrawal due to toxicity in early RA. In longstanding RA, after failure on 15-20 mg/week orally, a switch to 15 mg/week intramuscularly with subsequent dose escalation did not result in increased efficacy. CONCLUSIONS: Starting on methotrexate 15 mg/week orally, escalating with 5 mg/month to 25-30 mg/week, or the highest tolerable dose, with a subsequent switch to subcutaneous administration in the case of an insufficient response, seems to be the optimal evidence-based dosing and routing recommendation for methotrexate in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003) · Spine · doi:10.1097/01.brs.0000065484.95996.af · Cited by 2,180
Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
Self-citationStudies in Natural Products Chemistry
(1993) · Studies in Natural Products Chemistry · doi:10.1016/b978-0-444-89366-6.70001-0 · Cited by 1,743
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872
How to identify randomized controlled trials in MEDLINE: ten years on.
Glanville, J., Lefebvre, C., Miles, J. N. V., & Camosso‐Stefinovic, J. (2006) · Europe PMC (PubMed Central) · Cited by 833
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
Strand, V. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2542 · Cited by 754
Genovese, M. C., Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10308 · Cited by 733
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Methotrexate for Rheumatoid Arthritis
Kremer, J. M., Alarcón, G. S., Lightfoot, R. W., Willkens, R. F., Furst, D. E., Williams, H. J., Dent, P. B., & Weinblatt, M. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370304 · Cited by 607
Verstappen, S. M. M., Jacobs, J. W. G., van der Veen, M. J., Heurkens, A. H. M., Schenk, Y., ter Borg, E. J., Blaauw, A. A. M., & Bijlsma, J. W. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071092 · Cited by 566
van der Heijde, D., Klareskog, L., Rodriguez‐Valverde, V., Codreanu, C., Bolosiu, H., Melo‐Gomes, J., Tornero‐Molina, J., Wajdula, J., Pedersen, R., Fatenejad, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21655 · Cited by 535
Self-citationEvidence Based Medicine—How to Practice and Teach EBM
Jones, K. (1996) · BMJ · doi:10.1136/bmj.313.7069.1410 · Cited by 525
Visser, K., Katchamart, W., Loza, E., Martinez-Lopez, J. A., Salliot, C., Trudeau, J., Bombardier, C., Carmona, L., van der Heijde, D., Bijlsma, J. W. J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094474 · Cited by 491
Self-citation(2006) · Evidence‐based Medicine Toolkit · doi:10.1002/9780470750605.ch15 · Cited by 473
Emery, P., Breedveld, F. C., Lemmel, E. M., Kaltwasser, J. P., Dawes, P. T., Gömör, B., Van den Bosch, F., Nordström, D., Bjørneboe, O., Dahl, R., et al. (2000) · Rheumatology · doi:10.1093/rheumatology/39.6.655 · Cited by 472
Williams, H. J., Willkens, R. F., Samuelson, C. O., Alarcón, G. S., Guttadauria, M., Yarboro, C., Polisson, R. P., Weiner, S. R., Luggen, M. E., Billingsley, L. M., et al. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280702 · Cited by 462
Braun, J., Kästner, P., Flaxenberg, P., Währisch, J., Hanke, P., Demary, W., von Hinüber, U., Rockwitz, K., Heitz, W., Pichlmeier, U., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23144 · Cited by 348
Methotrexate in Rheumatoid Arthritis
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-418 · Cited by 345
Dougados, M., Combe, B., Cantagrel, A., Goupille, P., Olive, P., Schattenkirchner, M., Meusser, S., Paimela, L., Rau, R., Zeidler, H., et al. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.4.220 · Cited by 259
Kimpel, D. L. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79348-4 · Cited by 251
Haagsma, C. J., van Riel, P. L., de Jong, A. J., & van de Putte, L. B. (1997) · Rheumatology · doi:10.1093/rheumatology/36.10.1082 · Cited by 231
Hoekstra, M., HAAGSMA, C. J., Neef, C., Proost, J. H., Knuif, A., & van de Laar, M. A. F. J. (2004) · PubMed · Cited by 220
Haagsma, C. J., Blom, H. J., van Riel, P. L. C. M., van't Hof, M. A., Giesendorf, B. A. J., van Oppenraaij-Emmerzaal, D., & van de Putte, L. B. A. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2.79 · Cited by 207
Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid Arthritis
Bannwarth, B., Péhourcq, F., Schaeverbeke, T., & Dehais, J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630030-00002 · Cited by 206
Maetzel, A., Wong, A., Strand, V., Tugwell, P., Wells, G., & Bombardier, C. (2000) · Rheumatology · doi:10.1093/rheumatology/39.9.975 · Cited by 184
Fürst, D. E., Koehnke, R., Burmeister, L. F., et al. (1989) · PubMed · Cited by 179
Thompson, R. N., Watts, C., Edelman, J., Esdaile, J. M., & Russell, A. S. (1984) · PubMed · Cited by 178
Kosinski, M. R., Kujawski, S. C., Martin, R. W., Wanke, L. A., Buatti, M. C., Ware, J. E., & Perfetto, E. M. (2002) · PubMed · Cited by 163
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Emery, P., Keystone, E. C., Schiff, M. H., van Riel, P. L. C. M., Weinblatt, M. E., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061937 · Cited by 159
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Sieper, J., Emery, P., Keystone, E., Schiff, M., Mease, P. J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081430 · Cited by 153
Strand, V., Tugwell, P., Bombardier, C., Maetzel, A., Crawford, B., Dorrier, C., Thompson, A. K., Wells, G. A., & on behalf of the LEFLUNOMIDE RHEUMATOID ARTHRITIS INVESTIGATORS GROUP (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1870::aid-anr11>3.0.co;2-d · Cited by 136
Willkens, R. F., Urowitz, M. B., Stablein, D. M., McKendry, R. J. R., Berger, R. G., Box, J., Fiechtner, J. J., Fudman, E. J., Hudson, N. P., Marks, C. R., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350802 · Cited by 118
Infections during low-dose methotrexate treatmentin rheumatoid arthritis
Boerbooms, A. M. T., Kerstens, P. J. S. M., van Loenhout, J. W. A., et al. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80009-3 · Cited by 118
Verstappen, S. M. M., Jacobs, J. W. G., Bijlsma, J. W. J., Heurkens, A. H. M., van Booma-Frankfort, C., ter Borg, E. J., Hofman, D. M., & van der Veen, M. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11170 · Cited by 109
Wegrzyn, J., Adeleine, P., & Miossec, P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011593 · Cited by 81
Toxicity of anti‐rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis
van Jaarsveld, C. H. M., Jahangier, Z. N., Jacobs, J. W. G., Blaauw, A. A. M., van Albada-Kuipers, G. A., ter Borg, E. J., Brus, H. L. M., Schenk, Y., van der Veen, M. J., & Bijlsma, J. W. J. (2000) · Rheumatology · doi:10.1093/rheumatology/39.12.1374 · Cited by 55
Efficacy of Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/xxxiv.suppl_4.43 · Cited by 53
Bathon, J. M., & Genovese, M. C. (2003) · PubMed · Cited by 40
Rozin, A. P., Schapira, D., Balbir-Gurman, A., Braun‐Moscovici, Y., Markovits, D., Militianu, D., & Nahir, M. A. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.756 · Cited by 39
Hamilton, J., McInnes, I. B., Thomson, E. A., Porter, D., Hunter, J. A., Madhok, R., & Capell, H. A. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.6.566 · Cited by 34
Willkens, R. F., & Stablein, D. (1996) · PubMed · Cited by 20
Confidence intervals of effect size in randomized comparative parallel‐group studies
Wu, J., Jiang, G., & Wei, W. (2005) · Statistics in Medicine · doi:10.1002/sim.2346 · Cited by 16
The Utrecht experience with different treatment strategies in early rheumatoid arthritis.
Verstappen, S. M. M., Jacobs, J. W., & Bijlsma, J. W. J. (2004) · PubMed · Cited by 13
Azathioprine and methotrexate as combination chemotherapy in rheumatoid arthritis.
McKendry, R. J. R. (1990) · PubMed · Cited by 8
Cited by
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,941
Smolen, J. S., Landewé, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,710
Self-citationSmolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Treating rheumatoid arthritis to target: recommendations of an international task force
Smolen, J. S., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123919 · Cited by 2,100
Self-citation
Metadata
- Authors
- Visser, K., & van der Heijde, D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 68
- Issue
- 7
- Pages
- 1094-1099
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2121311666
- Cited by
- 328
- References
- 53
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.